DOX-encapsulating aptamosomes showed enhanced prostate cancer cell (PSMA positive) binding and uptake in vitro and, most importantly, was selectively retained in tumor tissue in vivo leading to reduced tumor size in xenograft mice. The gene discussed is FOLH1; the disease is prostate cancer.